Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Veterinary Oxygen Therapy Market Size & Growth Forecast 2026–2035, By Segments (Product, Animal Type, Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 13879| Published Date: May-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Veterinary Oxygen Therapy Market size stood at USD 1.28 Billion in 2025 and is predicted to grow at a 7.6% CAGR from 2026 to 2035, exceeding USD 2.66 Billion by 2035. The industry revenue for 2026 is assessed at USD 1.37 billion.

Base Year Value (2025)
USD 1.28 Billion
CAGR (2026-2035)
7.6%
Forecast Year Value (2035)
USD 2.66 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Veterinary Oxygen Therapy Market Intelligence Snapshot

Regional Market Dynamics

  • North America holds 40.81% share, supported by advanced veterinary infrastructure, widespread use of oxygen-based treatments, and strong adoption in emergency and post-operative animal care.
  • Asia Pacific is growing at 8.59% CAGR due to modernization of veterinary services and increasing adoption of respiratory support systems across companion animal care facilities.

Segment Momentum

  • Veterinary oxygen concentrators lead with 80.47% share due to reliable on-site oxygen delivery, reduced cylinder dependence, and operational efficiency in clinics for emergency care, surgery, and recovery support.
  • Small animals lead and grow fastest due to high treatment volumes in companion animals, where oxygen therapy is frequently required for surgery, respiratory distress, and emergency stabilization care.

Market Expansion Drivers

  • Rising respiratory and critical illness cases in animals driving oxygen therapy demand.
  • Expansion of veterinary hospitals and specialty clinics strengthening critical care infrastructure.
  • Development of portable oxygen systems enabling mobile and emergency veterinary care delivery.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Leading players in the veterinary oxygen therapy market include Koninklijke Philips N.V. (Netherlands), CAIRE Inc. (United States), Drive DeVilbiss International (United States), Longfian Scitech Co., Ltd. (China), Vetland Medical Sales & Services LLC (United States), RWD Life Science Co., Ltd. (China), IMEX Medical Limited (United Kingdom), Airnetics LLC (United States), AEOLUS International Pet Products, LLC (United States), Shinova Systems (India).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising respiratory and critical illness cases in animals driving oxygen therapy demand

A growing caseload of pneumonia, trauma, post-surgical complications, heat stress, cardiac distress, and other acute respiratory conditions is directly increasing utilization of oxygen cages, concentrators, masks, and related delivery systems in the veterinary oxygen therapy market. When animal patients present with compromised breathing or low oxygen saturation, oxygen support becomes an immediate stabilizing intervention rather than a discretionary purchase, which pushes clinics and hospitals to maintain reliable oxygen access and upgrade therapy equipment. This pattern is also influencing purchasing behavior toward systems that can support continuous monitoring, rapid setup, and species-appropriate delivery, reinforcing market demand through everyday emergency and intensive care use.

Expansion of veterinary hospitals and specialty clinics strengthening critical care infrastructure

As veterinary care shifts toward larger hospitals and referral-based specialty clinics, providers are investing in emergency rooms, ICUs, surgical suites, and inpatient recovery areas that require dedicated oxygen delivery capability. That infrastructure buildout supports market expansion for the veterinary oxygen therapy market because oxygen systems are embedded in critical care readiness, not treated as standalone add-ons. Facilities with broader case complexity also tend to standardize oxygen access across treatment areas, increasing procurement of centralized systems, backup supply arrangements, and higher-specification equipment suited to continuous use in anesthesia, recovery, and emergency stabilization.

Development of portable oxygen systems enabling mobile and emergency veterinary care delivery

Portable concentrators, cylinders, and compact delivery setups are changing how oxygen support is deployed by making it practical in ambulatory practice, transport, field response, and point-of-rescue treatment. In the veterinary oxygen therapy market, this is increasing market penetration beyond fixed clinical settings, since veterinarians can initiate stabilization during transit or in locations where permanent oxygen infrastructure is unavailable. The practical effect is a broader range of use cases for oxygen therapy, with buyers placing greater value on lightweight design, battery operation, durability, and ease of deployment under emergency conditions.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising respiratory and critical illness cases in animals driving oxygen therapy demand 2.00% Moderate North America High Near Term
Expansion of veterinary hospitals and specialty clinics strengthening critical care infrastructure 1.70% Moderate North America, Asia Pacific High Mid Term
Development of portable oxygen systems enabling mobile and emergency veterinary care delivery 1.60% Low Asia Pacific, North America Emerging Long Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
40.81% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 40.81% share of the veterinary oxygen therapy market in 2025, supported by a well-established companion animal care ecosystem, broad availability of advanced veterinary equipment, and higher utilization of intensive and post-operative respiratory support in animal hospitals and specialty clinics. The region’s leadership is strengthened by routine adoption of oxygen concentrators, masks, cages, and monitoring systems in clinical practice, where veterinarians are more likely to use supportive oxygen treatment for emergency care, anesthesia recovery, and chronic respiratory conditions.

Asia Pacific is projected to expand at an 8.59% CAGR over the forecast period, with growth in the veterinary oxygen therapy market being fueled by the gradual modernization of veterinary infrastructure and rising access to clinical care for companion animals. Demand is accelerating as more veterinary facilities incorporate respiratory support capabilities into everyday treatment settings, particularly where improving pet care standards and expanding animal health services are increasing the practical use of oxygen delivery systems in both acute and ongoing care.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Clinical Equipment Standardization

Germany prioritizes veterinary oxygen therapy equipment that integrates smoothly into modern clinical workflows while meeting demanding quality expectations. Healthcare providers focus on dependable respiratory support systems for surgical procedures and intensive animal care.

France 🇫🇷

Integrated Respiratory Support

France incorporates veterinary oxygen therapy into comprehensive treatment protocols for companion animals requiring respiratory stabilization and recovery support. Clinics favor equipment offering dependable performance and compatibility with broader critical care infrastructure.

Italy 🇮🇹

Practice Modernization Focus

Italy is modernizing veterinary practices through investment in oxygen therapy equipment that supports emergency treatment and surgical recovery. Veterinary professionals value practical systems that improve treatment consistency while remaining adaptable to varied clinic sizes.

Japan 🇯🇵

Companion Care Enhancement

Japan continues expanding veterinary oxygen therapy adoption as clinics strengthen services for aging companion animals with respiratory conditions. Purchasing decisions emphasize compact equipment, operational reliability, and efficient integration into limited clinical spaces.

South Korea 🇰🇷

Specialty Clinic Development

South Korea is expanding veterinary oxygen therapy capabilities as specialty animal hospitals broaden emergency and postoperative treatment services. Demand centers on user-friendly systems that enhance patient monitoring and respiratory care efficiency.

United States 🇺🇸

Advanced Critical Care

The U.S. veterinary oxygen therapy market is supported by growing investment in advanced companion animal treatment and emergency care capabilities. Veterinary hospitals increasingly adopt versatile oxygen delivery systems that improve respiratory support across diverse clinical settings.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Veterinary Oxygen Therapy Market Share (%), Product, 2025

Veterinary Oxygen Concentrator
Accessories

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Product Segment Analysis: Veterinary Oxygen Concentrator (Largest & Fastest-Growing Segment)

By 2025, Veterinary Oxygen Concentrator held an 80.47% share of the veterinary oxygen therapy market, reflecting its established role as the core oxygen delivery solution in routine and critical animal care settings. its position is reinforced through the practical need for reliable, on-site oxygen supply in veterinary clinics and hospitals, where continuous access, ease of operation, and reduced dependence on cylinder logistics improve day-to-day treatment efficiency. The same operating advantages are also sustaining growth momentum in the veterinary oxygen therapy market, as providers increasingly favor equipment that fits compact clinical environments while supporting faster response in respiratory distress, anesthesia recovery, and intensive care use.

Animal Type Segment Analysis: Small Animals (Largest & Fastest-Growing Segment)

In the veterinary oxygen therapy market, Small Animals represented the leading segment in 2025 and accounted for the largest share, while also maintaining the strongest growth momentum. This position is grounded in the high volume of clinical visits for dogs, cats, and other companion animals, where respiratory support is commonly required during surgery, emergency stabilization, and recovery care. Growth continues to concentrate in this segment because veterinary practices are structured primarily around small animal treatment, making oxygen therapy adoption more immediate and operationally relevant here than in alternatives with lower treatment frequency or more specialized care settings.

Segment Sub-Segment Largest Segment Fastest Growing
Product Veterinary Oxygen Concentrator, Accessories Veterinary Oxygen Concentrator Veterinary Oxygen Concentrator
Animal Type Small Animals, Large Animals, Others Small Animals Small Animals
Application ICU, Homecare Setting/postoperative Care, Others ICU Homecare Setting/postoperative Care
End-use Veterinary Hospitals, Veterinary Clinics, Others Veterinary Hospitals Veterinary Clinics
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the veterinary oxygen therapy market:

1. Koninklijke Philips N.V. (Netherlands)

2. CAIRE Inc. (United States)

3. Drive DeVilbiss International (United States)

4. Longfian Scitech Co. Ltd. (China)

5. Vetland Medical Sales & Services LLC (United States)

6. RWD Life Science Co. Ltd. (China)

7. IMEX Medical Limited (United Kingdom)

8. Airnetics LLC (United States)

9. AEOLUS International Pet Products LLC (United States)

10. Shinova Systems (India)

The veterinary oxygen therapy market is witnessing growing focus on critical care support solutions for animals. Equipment innovation is improving oxygen delivery precision and treatment safety. Rising veterinary healthcare standards are supporting broader adoption across clinical settings.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Bionet America Feb-25 Bionet America launched the Super Air Smart ICU in February 2025, a next-generation veterinary critical care unit integrating advanced oxygenation, CO₂ management without soda-lime, ionization-based air purification, and climate control. The system aims to reduce operational workload and improve patient safety, positioning the company in high-end veterinary intensive care solutions.
Infinium Medical Jan-25 Infinium Medical entered an exclusive distribution partnership in January 2025 for Vapotherm VET 2.0, a high-flow oxygen therapy system for veterinary applications. The system enhances respiratory care through improved mobility, user-friendly design, and advanced medication delivery capabilities, strengthening Infinium’s veterinary portfolio and expanding access to advanced oxygen therapy technologies in clinical settings.
BMV Animal Technology Mar-25 BMV Animal Technology introduced the BAM-5 Pro Turbo Ventilator and BAM-2 Oxygen Concentrator in March 2025, expanding its veterinary respiratory care portfolio. These devices enhance critical care capabilities in animal hospitals by improving ventilation efficiency and oxygen delivery, strengthening the company’s position in veterinary medical technology solutions.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Veterinary Oxygen Therapy Market — Custom Segments

Segment Sub-Segment
No segment data available.

Veterinary Oxygen Therapy Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How much revenue does the veterinary oxygen therapy market generate?

The market size of the veterinary oxygen therapy is estimated at USD 1.37 billion in 2026.

How much is the veterinary oxygen therapy industry expected to grow by 2035?

Veterinary Oxygen Therapy Market size is anticipated to rise from USD 1.28 billion in 2025 to USD 2.66 billion by 2035 reflecting a CAGR surpassing 7.6% over the forecast horizon of 2026-2035.

How are rising respiratory and critical illness cases driving demand in the veterinary oxygen therapy market?

Increasing cases of respiratory distress, trauma, and post-surgical complications are making oxygen therapy a critical intervention in veterinary care. Clinics are prioritizing reliable oxygen delivery systems for stabilization, monitoring, and emergency treatment workflows.

How is the expansion of veterinary hospitals influencing oxygen therapy adoption?

Growth of specialty clinics and veterinary hospitals is embedding oxygen systems into ICU and surgical infrastructure. This increases procurement of centralized oxygen setups and high-spec equipment for continuous critical care and emergency readiness.

Why does veterinary oxygen concentrator dominate the market?

Veterinary oxygen concentrators lead with 80.47% share due to reliable on-site oxygen delivery, reduced cylinder dependence, and operational efficiency in clinics for emergency care, surgery, and recovery support.

Which animal segment is driving growth in veterinary oxygen therapy?

Small animals lead and grow fastest due to high treatment volumes in companion animals, where oxygen therapy is frequently required for surgery, respiratory distress, and emergency stabilization care.

Why does North America lead the veterinary oxygen therapy market?

North America holds 40.81% share, supported by advanced veterinary infrastructure, widespread use of oxygen-based treatments, and strong adoption in emergency and post-operative animal care.

How is Asia Pacific driving growth in this market?

Asia Pacific is growing at 8.59% CAGR due to modernization of veterinary services and increasing adoption of respiratory support systems across companion animal care facilities.

What are the prominent companies operating in the veterinary oxygen therapy landscape?

Leading players in the veterinary oxygen therapy market include Koninklijke Philips N.V. (Netherlands), CAIRE Inc. (United States), Drive DeVilbiss International (United States), Longfian Scitech Co., Ltd. (China), Vetland Medical Sales & Services LLC (United States), RWD Life Science Co., Ltd. (China), IMEX Medical Limited (United Kingdom), Airnetics LLC (United States), AEOLUS International Pet Products, LLC (United States), Shinova Systems (India).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →